The Royal College of Nursing (RCN) has officially terminated its commercial partnership with Teva UK, a subsidiary of the Israeli pharmaceutical company Teva Pharmaceutical Industries. The Guardian reports that the nursing union moved to sever ties with the firm due to concerns regarding the company’s connections to Israel’s military and its broader corporate track record.
Partnership details and corporate links
The RCN had maintained a commercial relationship with Teva UK, which operates as a major supplier of generic medicines within the British healthcare system. The decision to conclude this partnership follows internal and external scrutiny of the company’s ties to Israel, including its corporate activities and documented associations with the country's military apparatus.
Union response
The move represents a policy decision by the leadership of the Royal College of Nursing to distance the professional body from specific international corporate entities. The Guardian notes that the action was taken to address member concerns regarding the ethical implications of the union’s commercial associations. Neither the RCN nor Teva UK have released additional statements regarding the immediate financial impact of this contract cancellation on union-led nursing initiatives.
The Royal College of Nursing is expected to begin a review of its remaining commercial partnerships to ensure all future corporate affiliations align with the union's updated internal policy framework.